|  | Oxidation trial | Performance trial |
---|---|---|---|
VO2 (L.min-1) | P | 2.65 ± 0.07 | N/A |
MD | 2.69 ± 0.06 | N/A | |
MD + F | 2.70 ± 0.09 | N/A | |
Power (W) | P | 176.3 ± 6.95 | 201.0 ± 22.4 |
 | MD | 175.0 ± 6.67 | 197.6 ± 21.6 |
 | MD + F | 174.4 ± 6.59 | 227.0 ± 23.2* |
Heart rate (b.min-1) | P | 128.7 ± 4.7 | 149.0 ± 6.3 |
 | MD | 132.4 ± 3.7 | 151.9 ± 6.3 |
 | MD + F | 133.1 ± 4.4†| 160.7 ± 5.0* |
Blood glucose (mmol.L-1) | P | 3.90 ± 0.11 | 3.24 ± 0.25 |
MD | 4.77 ± 0.12†| 4.17 ± 0.22†| |
MD + F | 4.97 ± 0.12†| 4.18 ± 0.23†| |
RPETOTAL (6–20 scale) | P | 11.9 ± 0.6 | 15.6 ± 0.6 |
MD | 12.2 ± 0.5 | 16.3 ± 0.5 | |
MD + F | 11.6 ± 0.6 | 16.4 ± 0.7 | |
RPELEGS (0–10 scale) | P | 3.8 ± 0.4 | 7.1 ± 0.4 |
MD | 4.2 ± 0.5 | 7.1 ± 0.3 | |
 | MD + F | 3.3 ± 0.4‡ | 6.9 ± 0.6 |